Literature DB >> 9486990

Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.

Q Xiao1, M J Danton, D P Witte, M C Kowala, M T Valentine, J L Degen.   

Abstract

A critical role of the coagulation system in the development of atherosclerosis has been frequently postulated based on a variety of indirect observations, including the expression of procoagulants and fibrinolytic factors within atherosclerotic vessels, the presence of substantial amounts of fibrin(ogen) and fibrin degradation products within intimal lesions, the cellular infiltration and assimilation of mural thrombi into developing plaques, and the identification of high plasma fibrinogen (Fib) levels as an independent risk factor for the development of ischemic heart disease. To directly examine the role of fibrin(ogen) in atherogenesis, Fib-deficient mice were crossed to atherosclerosis-prone apolipoprotein E (apo E)-deficient mice. Both apo E-/- and apo E-/-/Fib-/- mice developed lesions throughout the entire aortic tree, ranging in appearance from simple fatty streaks to complex fibrous plaques. Furthermore, remarkably little difference in lesion size and complexity was observed within the aortae of age- and gender-matched apo E-/- and apo E-/-/Fib-/- mice. These results indicate that the contribution of fibrin(ogen) to intimal mass and local cell adhesion, migration, and proliferation is not strictly required for the development of advanced atherosclerotic disease in mice with a severe defect in lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486990      PMCID: PMC508671          DOI: 10.1172/JCI1461

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Relationships of thrombosis and fibrinolysis to atherosclerosis.

Authors:  A Hamsten; P Eriksson; F Karpe; A Silveira
Journal:  Curr Opin Lipidol       Date:  1994-10       Impact factor: 4.776

2.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.

Authors:  S Ishibashi; J L Goldstein; M S Brown; J Herz; D K Burns
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

4.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.

Authors:  R L Reddick; S H Zhang; N Maeda
Journal:  Arterioscler Thromb       Date:  1994-01

5.  Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.

Authors:  D J Grainger; P R Kemp; A C Liu; R M Lawn; J C Metcalfe
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

6.  Human leukemia inhibitory factor inhibits development of experimental atherosclerosis.

Authors:  C S Moran; J H Campbell; D L Simmons; G R Campbell
Journal:  Arterioscler Thromb       Date:  1994-08

7.  Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.

Authors:  L E Odekon; F Blasi; D B Rifkin
Journal:  J Cell Physiol       Date:  1994-03       Impact factor: 6.384

8.  Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.

Authors:  Y Katagiri; T Hiroyama; N Akamatsu; H Suzuki; H Yamazaki; K Tanoue
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

Review 10.  Role of thrombosis in atherosclerosis and its complications.

Authors:  E Falk; A Fernández-Ortiz
Journal:  Am J Cardiol       Date:  1995-02-23       Impact factor: 2.778

View more
  13 in total

1.  Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Authors:  Nevin Oruc; Yaman Tokat; Refik Killi; Murat Tombuloglu; Tankut Ilter
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.

Authors:  K Tordjman; C Bernal-Mizrachi; L Zemany; S Weng; C Feng; F Zhang; T C Leone; T Coleman; D P Kelly; C F Semenkovich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 3.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

4.  Thromboembolic events in patients with severe inherited fibrinogen deficiency.

Authors:  Amihai Rottenstreich; Avigal Lask; Lilliana Schliamser; Ariella Zivelin; Uri Seligsohn; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 5.  Genetic modifiers of atherosclerosis in mice.

Authors:  J W Knowles; N Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

6.  No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease.

Authors:  Raúl Altman; Jorge Rouvier; Alejandra Scazziota; Claudio Gonzalez
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

7.  The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

8.  Animal models of ischemic stroke. Part one: modeling risk factors.

Authors:  Marco Bacigaluppi; Giancarlo Comi; Dirk M Hermann
Journal:  Open Neurol J       Date:  2010-06-15

Review 9.  The hemostasis system in murine atherosclerosis.

Authors:  Takayuki Iwaki; Victoria A Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

10.  Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.

Authors:  X J Lou; N W Boonmark; F T Horrigan; J L Degen; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.